VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
GSK plc vs Wolters Kluwer N.V.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
GSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Wolters Kluwer N.V.
WKL · Euronext Amsterdam
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Wolters Kluwer N.V.'s moat claims, evidence, and risks.
View WKL analysisComparison highlights
- Moat score gap: Wolters Kluwer N.V. leads (73 / 100 vs 62 / 100 for GSK plc).
- Segment focus: GSK plc has 3 segments (37.6% in Specialty Medicines); Wolters Kluwer N.V. has 5 segments (26.8% in Health).
- Moat breadth: GSK plc has 4 moat types across 3 domains; Wolters Kluwer N.V. has 6 across 2.
Primary market context
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Wolters Kluwer N.V.
Health
Clinical decision support and clinical drug information solutions (point-of-care) for healthcare providers
Global
Hospitals/health systems, clinicians, payers, and academic institutions
Software + expert content provider
26.8%
Side-by-side metrics
Moat coverage
Shared moat types
GSK plc strengths
Wolters Kluwer N.V. strengths
Segment mix
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Wolters Kluwer N.V. segments
Full profile >Health
Oligopoly
Tax & Accounting
Oligopoly
Financial & Corporate Compliance
Oligopoly
Legal & Regulatory
Oligopoly
Corporate Performance & ESG
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.